These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32278777)

  • 1. Management of anticoagulation in adult patients with chronic parenchymal or vascular liver disease: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.
    Ollivier-Hourmand I; Nguyen N; De Gottardi A; Valla D; Hillaire S; Dutheil D; Bureau C; Hernandez-Gea V; De Raucourt E; Plessier A
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):438-446. PubMed ID: 32278777
    [No Abstract]   [Full Text] [Related]  

  • 2. Hereditary hemorrhagic telangiectasia and liver involvement: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.
    Silvain C; Thévenot T; Colle I; Vilgrain V; Dupuis-Girod S; Buscarini E; Valla D; Hillaire S; Dutheil D; Sitbon O; Bureau C; Plessier A
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):426-432. PubMed ID: 32276767
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk factors for vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.
    Soret J; Debray D; Fontbrune FS; Kiladjian JJ; Saadoun D; Latour RP; Valla D; Hernandez-Gea V; Hillaire S; Dutheil D; Plessier A; Bureau C; De Raucourt E
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):410-419. PubMed ID: 32651075
    [No Abstract]   [Full Text] [Related]  

  • 4. Pregnancy and vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.
    Payancé A; Ceccaldi PF; De Raucourt E; Valla D; Hillaire S; Dutheil D; Hernandez-Gea V; Bureau C; Plessier A
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):433-437. PubMed ID: 32278776
    [No Abstract]   [Full Text] [Related]  

  • 5. Porto-sinusoidal vascular disease. Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.
    Giudicelli H; Rautou PE; Paradis V; Bedossa P; Goria O; Lambert V; Hernandez-Gea V; Dutheil D; Plessier A; Bureau C; Valla D
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):447-451. PubMed ID: 32335045
    [No Abstract]   [Full Text] [Related]  

  • 6. "Vascular liver diseases: Position paper(s) from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and the European Reference Network on Hepatological Diseases (ERN RARE-LIVER)".
    Plessier A; Bureau C
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):407-409. PubMed ID: 32360056
    [No Abstract]   [Full Text] [Related]  

  • 7. Congenital portosystemic shunts: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.
    Guérin F; Franchi Abella S; McLin V; Ackermann O; Girard M; Cervoni JP; Savale L; Hernandez-Gea V; Valla D; Hillaire S; Dutheil D; Bureau C; Gonzales E; Plessier A
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):452-459. PubMed ID: 32279979
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombosis and anticoagulation in the setting of renal or liver disease.
    Ribic C; Crowther M
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):188-195. PubMed ID: 27913479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation in patients with advanced liver disease: an open issue.
    Violi F; Loffredo L; Pastori D
    Intern Emerg Med; 2021 Jan; 16(1):61-71. PubMed ID: 33073317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?
    Hugenholtz GC; Northup PG; Porte RJ; Lisman T
    Blood Rev; 2015 Mar; 29(2):127-36. PubMed ID: 25468718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular liver disorders: radiology at the center of patient management.
    Ronot M; Venkatesh SK
    Abdom Radiol (NY); 2018 Aug; 43(8):1885. PubMed ID: 29948058
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombosis and anticoagulation in liver disease.
    Valla DC
    Hepatology; 2008 Apr; 47(4):1384-93. PubMed ID: 18318436
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinico-statistical findings in chronic peripheral obliterating arteriopathy].
    Lombardo F; Gallotti R
    Chir Patol Sper; 1968 Feb; 6():Suppl 6:796+. PubMed ID: 5743528
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experiences with anticoagulant therapy of chronic arterial occlusion in reconstructive vascular surgery].
    Eide M; Koch G
    Wien Klin Wochenschr; 1972 May; 84(18):295-7. PubMed ID: 5023446
    [No Abstract]   [Full Text] [Related]  

  • 15. Microcirculatory pathology.
    Penner JA
    Adv Otorhinolaryngol; 1973; 20():236-43. PubMed ID: 4710509
    [No Abstract]   [Full Text] [Related]  

  • 16. Benign and malignant hepatocellular lesions in patients with vascular liver diseases.
    Vilgrain V; Paradis V; Van Wettere M; Valla D; Ronot M; Rautou PE
    Abdom Radiol (NY); 2018 Aug; 43(8):1968-1977. PubMed ID: 29460040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is coagulopathy a contraindication for thromboprophylaxis?
    Thachil J
    QJM; 2013 Dec; 106(12):1155-6. PubMed ID: 24065836
    [No Abstract]   [Full Text] [Related]  

  • 18. Considerations for Systemic Anticoagulation in ESRD.
    Dager WE; Tsu LV; Pon TK
    Semin Dial; 2015; 28(4):354-62. PubMed ID: 25951901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis promoting changes in chronic liver diseases.
    Rák K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):333-9. PubMed ID: 2465226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Should we add antiplatelet therapy to oral anticoagulation in patients with atrial fibrillation and vascular disease? Review of available evidence].
    Andreu JM; Roldán V; García-Navarro M; Ruipérez JA; Valdés M; Marín F
    Arch Cardiol Mex; 2012; 82(3):248-51. PubMed ID: 23021363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.